Skip to main content
Log in

Ex-vivo-Herzperfusion zur Steigerung der Organverfügbarkeit

Ex vivo heart perfusion for increasing organ availability

  • Übersichten
  • Published:
Zeitschrift für Herz-,Thorax- und Gefäßchirurgie Aims and scope

Zusammenfassung

Hintergrund

Die Herztransplantation stellt nach wie vor den Goldstandard für Patienten mit terminaler Herzinsuffizienz dar. Durch den Mangel an Spenderorganen erlangt die Anwendung der Ex-vivo-Herzperfusion zunehmende Bedeutung in der Rekonditionierung marginaler Spenderorgane.

Ziel der Arbeit

Neue Entwicklungen auf dem Gebiet der Ex-vivo-Herzperfusion sollen aufgezeigt und die praktische Anwendung bei der Organentnahme dargestellt werden.

Material und Methoden

Hierzu wird die Anwendung des Organ Care System (OCS; Fa. TransMedics, Inc., Andover, MA, USA) zur Evaluierung und zur Konditionierung von marginalen Spenderorganen vor dem Hintergrund des eklatanten Organmangels diskutiert.

Ergebnisse

Die OCS-Präservation ist im Vergleich zur kalten Kardioplegie in der klinischen Anwendung als gleichwertig einzustufen. Das OCS Heart reduziert hochsignifikant die kalte Ischämiezeit, sodass längere Transportzeiten und konsekutiv ein größerer Entnahmeradius für Spenderherzen möglich sind. „Extended criteria donors“ können bei professioneller Anwendung mit dem OCS zu geeigneten Spenderorganen konditioniert werden. Die Reanimation von „Donation-after-cardiac-death“(DCD)-Herzen mithilfe des OCS wurde international klinisch etabliert und zeigt vielversprechende Ergebnisse.

Schlussfolgerung

Wir postulieren die standardisierte Anwendung der Ex-vivo-Herzperfusion für marginale Organe zur Erweiterung des potenziellen Spender-Pools.

Abstract

Background

Heart transplantation still remains the gold standard for patients with end-stage heart failure. Due to the lack of donor organs the use of ex vivo heart perfusion is becoming increasingly more important for reconditioning marginal donor organs.

Objective

New developments in the field of ex vivo heart perfusion are presented with an emphasis on the practical application in a donor organ retrieval service.

Material and methods

The utilization of the Organ Care System (OCS, TransMedics, Andover, MA) for evaluation and reconditioning of marginal donor organs is discussed in the light of the substantial shortage of donor organs.

Results

Preservation using the OCS can be considered as being equivalent to cold cardioplegia in the clinical application. An OCS heart shows a highly significant reduction in the cold ischemia time so that longer transport times and subsequently greater catchment areas are possible. Extended criteria donors can be conditioned to be suitable donor organs by the professional application of the OCS. Resuscitation of so-called donation after cardiac death (DCD) donor hearts using OCS has been clinically established internationally and the results are very promising.

Conclusion

We postulate the standardized application of ex vivo heart perfusion for marginal donor organs to extend the potential donor pool.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6

Literatur

  1. Fatullayev J, Samak M, Sabashnikov A, Zeriouh M, Rahmanian PB, Choi YH, Schmack B, Kallenbach K, Ruhparwar A, Eghbalzadeh K, Dohmen PM, Karck M, Wippermann J, Wahlers T, Popov AF, Simon AR, Weymann A (2015) Continuous-Flow Left Ventricular Assist Device Thrombosis: A Danger Foreseen is a Danger Avoided. Med Sci Monit Basic Res 1(21):141–144. doi:10.12659/MSMBR.894840

    Article  Google Scholar 

  2. Loganathan S, Radovits T, Hirschberg K, Korkmaz S, Koch A, Karck M, Szabó G (2010) Effects of Custodiol-N, a novel organ preservation solution, on ischemia/reperfusion injury. J Thorac Cardiovasc Surg 139(4):1048–1056. doi:10.1016/j.jtcvs.2009.09.034.

    Article  CAS  PubMed  Google Scholar 

  3. Popov AF, García Sáez D, Sabashnikov A, Patil NP, Zeriouh M, Mohite PN, Zych B, Schmack B, Ruhparwar A, Kallenbach K, Dohmen PM, Karck M, Simon AR, Weymann A (2015) Utilization of the organ care system – a game-changer in combating donor organ shortage. Med Sci Monit Basic Res 21:29–32. doi:10.12659/MSMBR.894020

    Article  PubMed  PubMed Central  Google Scholar 

  4. Popov AF, Sabashnikov A, Patil NP, Zeriouh M, Mohite PN, Zych B, Saez DG, Schmack B, Ruhparwar A, Dohmen PM, Karck M, Simon AR, Weymann A (2015) Ex vivo lung perfusion – state of the art in lung donor pool expansion. Med Sci Monit Basic Res 3(21):9–14. doi:10.12659/MSMBR.893674

    Google Scholar 

  5. Ghodsizad A, Bordel V, Ungerer M, Karck M, Bekeredjian R, Ruhparwar A (2012) Ex vivo coronary angiography of a donor heart in the organ care system. Heart Surg Forum 15(3):E161–E163. doi:10.1532/HSF98.20111146

    Article  PubMed  Google Scholar 

  6. García Sáez D, Zych B, Sabashnikov A, Bowles CT, De Robertis F, Mohite PN, Popov AF, Maunz O, Patil NP, Weymann A, Pitt T, McBrearty L, Pates B, Hards R, Amrani M, Bahrami T, Banner NR, Simon AR (2014) Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile. Ann Thorac Surg 98(6):2099–2105. doi:10.1016/j.athoracsur.2014.06.098.

    Article  PubMed  Google Scholar 

  7. Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J (2015) PROCEED II trial investigators. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet 385(9987):2577–2584. doi:10.1016/S0140-6736(15)60261-6.

    Article  PubMed  Google Scholar 

  8. Dhital KK, Iyer A, Connellan M, Chew HC, Gao L, Doyle A, Hicks M, Kumarasinghe G, Soto C, Dinale A, Cartwright B, Nair P, Granger E, Jansz P, Jabbour A, Kotlyar E, Keogh A, Hayward C, Graham R, Spratt P, Macdonald P (2015) Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series. Lancet 385(9987):2585–2591. doi:10.1016/S0140-6736(15)60038-1.

    Article  PubMed  Google Scholar 

  9. Daemen JW, Kootstra G, Wijnen RM, Yin M, Heineman E (1994) Nonheart-beating donors: the Maastricht experience. Clin Transpl 303–316

  10. García Sáez D, Elbetanony A, Lezberg P, Hassanein A, Bowles CT, Popov AF, Zych B, Sabashnikov A, Mohite P, Simon AR (2015) Ex vivo heart perfusion after cardiocirculatory death; a porcine model. J Surg Res 195(1):311–314. doi:10.1016/j.jss.2014.12.039.

    Article  PubMed  Google Scholar 

  11. Iyer A, Gao L, Doyle A, Rao P, Cropper JR, Soto C, Dinale A, Kumarasinghe G, Jabbour A, Hicks M, Jansz PC, Feneley MP, Harvey RP, Graham RM, Dhital KK, MacDonald PS (2015) Normothermic ex vivo perfusion provides superior organ preservation and enables viability assessment of hearts from DCD donors. Am J Transplant 15(2):371–380. doi:10.1111/ajt.12994

    Article  CAS  PubMed  Google Scholar 

  12. Boucek MM, Mashburn C, Dunn SM, Frizell R, Edwards L, Pietra B, Campbell D, Denver Children’s Pediatric Heart Transplant Team (2008) Pediatric heart transplantation after declaration of cardiocirculatory death. N Engl J Med 359(7):709–714. doi:10.1056/NEJMoa0800660

    Article  CAS  PubMed  Google Scholar 

  13. Ali A, White P, Dhital K, Ryan M, Tsui S, Large S (2009) Cardiac recovery in a human non-heart-beating donor after extracorporeal perfusion: source for human heart donation? J Heart Lung Transplant 28(3):290–293. doi:10.1016/j.healun.2008.12.014

    Article  PubMed  Google Scholar 

  14. Iyer A, Gao L, Doyle A, Rao P, Jayewardene D, Wan B, Kumarasinghe G, Jabbour A, Hicks M, Jansz PC, Feneley MP, Harvey RP, Graham RM, Dhital KK, Macdonald PS (2014) Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning. Am J Transplant 8:1744–1752

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Weymann.

Ethics declarations

Interessenkonflikt

A. Weymann, A. Sabashnikov, M. Zeriouh, A. Ruhparwar, A. R. Simon und A.-F. Popov geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weymann, A., Sabashnikov, A., Zeriouh, M. et al. Ex-vivo-Herzperfusion zur Steigerung der Organverfügbarkeit. Z Herz- Thorax- Gefäßchir 30, 140–146 (2016). https://doi.org/10.1007/s00398-015-0051-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00398-015-0051-4

Schlüsselwörter

Keywords

Navigation